Creon 20,000 Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

creon 20,000

viatris limited - pancreatin 300mg (amylase 16,000 ph eur u, lipase 20,000 ph eur u, protease 1,200 ph eur u.) - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 16,000 ph eur u, lipase 20,000 ph eur u, protease 1,200 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Creon 35 000 gastro-resistant capsules, hard Մալթա - անգլերեն - Malta Medicines Authority

creon 35 000 gastro-resistant capsules, hard

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - gastro-resistant hard capsule - pancreatin 420 mg - digestives, incl. enzymes

Creon 20 000 gastro-resistant capsules, hard Մալթա - անգլերեն - Malta Medicines Authority

creon 20 000 gastro-resistant capsules, hard

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - gastro-resistant hard capsule - pancreatin 300 mg - digestives, incl. enzymes

Creon Capsule 10000 Մալթա - անգլերեն - Malta Medicines Authority

creon capsule 10000

abbott healthcare products limited - pancreatin 150 mg - capsule

Creon 150mg Capsule Ֆիլիպիններ - անգլերեն - FDA (Food And Drug Administration)

creon 150mg capsule

abbott laboratories gmbh; importer: abbott laboratories; distributor: zuellig pharma corp. - pancreatin - capsule - 150mg